| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Mar 24 | Ambrx Biopharma | Common Stock | Sale back to company | Dispose D | No | No | 0 | 48,202 | 0.00 | 0 |
| 7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 16.66 | 173,785 | 2.90 mm | 0 |
| 7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 0.91 | 772,857 | 703.30 k | 0 |
| 7 Mar 24 | Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 750,000 | 0.00 | 0 |
| 7 Mar 24 | Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 294,643 | 0.00 | 0 |
| 4 Jan 24 | SEELQ Seelos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.33 | 1,666 | 2.22 k | 1,666 |
| 11 Dec 23 | Ambrx Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 750,000 | 0.00 | 1,363,332 |
| 27 Oct 23 | Ambrx Biopharma | Common Stock | Sell | Dispose S | No | Yes | 9.82 | 50,012 | 491.12 k | 342,845 |
